Global Over the Counter (OTC) Analgesics Market 2023-2027

Description

List of Tables

The over the counter (OTC) analgesics market is forecasted to grow by USD 6525.59 mn during 2022-2027, accelerating at a CAGR of 4.74% during the forecast period. The report on the over the counter (OTC) analgesics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing aging population globally, increasing prevalence of pain-related conditions, and growing number of mergers and acquisitions (M and A) activities.

Technavio's over the counter (OTC) analgesics market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	4.51%
CAGR	4.74%
Incremental Value	$6525.59mn

By Type

Internal
External

By Distribution Channel

Offline
Online

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing number of launches of OTC analgesics as one of the prime reasons driving the over the counter (OTC) analgesics market growth during the next few years. Also, rising self-medication and awareness among consumers regarding OTC drugs and growing presence of e-pharmacy will lead to sizable demand in the market.

The report on the over the counter (OTC) analgesics market covers the following areas:

Over the counter (OTC) analgesics market sizing
Over the counter (OTC) analgesics market forecast
Over the counter (OTC) analgesics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading over the counter (OTC) analgesics market vendors that include AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Cardinal Health Inc., Cipla Ltd., CV Sciences Inc., Endo International Plc, GlaxoSmithKline Plc, Medterra CBD, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc, Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Weefsel Pharma, and AKUMS. Also, the over the counter (OTC) analgesics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43442

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary €" Chart on Market Overview
Exhibit 02: Executive Summary €" Data Table on Market Overview
Exhibit 03: Executive Summary €" Chart on Global Market Characteristics
Exhibit 04: Executive Summary €" Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary €" Chart on Market Segmentation by Type
Exhibit 06: Executive Summary €" Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary €" Chart on Incremental Growth
Exhibit 08: Executive Summary €" Data Table on Incremental Growth
Exhibit 09: Executive Summary €" Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global over the counter analgesics market 2017 - 2021
Exhibit 18: Historic Market Size €" Data Table on global over the counter analgesics market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size €" Type Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size €" Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size €" Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size €" Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers €" Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers €" Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants €" Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes €" Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry €" Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Internal - Market size and forecast 2022-2027
Exhibit 34: Chart on Internal - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Internal - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Internal - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Internal - Year-over-year growth 2022-2027 (%)
6.4 External - Market size and forecast 2022-2027
Exhibit 38: Chart on External - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on External - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on External - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on External - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 56: Market opportunity by Distribution Channel ($ million)
Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 AstraZeneca Plc
Exhibit 107: AstraZeneca Plc - Overview
Exhibit 108: AstraZeneca Plc - Product / Service
Exhibit 109: AstraZeneca Plc - Key news
Exhibit 110: AstraZeneca Plc - Key offerings
12.4 Bayer AG
Exhibit 111: Bayer AG - Overview
Exhibit 112: Bayer AG - Business segments
Exhibit 113: Bayer AG - Key news
Exhibit 114: Bayer AG - Key offerings
Exhibit 115: Bayer AG - Segment focus
12.5 Boehringer Ingelheim International GmbH
Exhibit 116: Boehringer Ingelheim International GmbH - Overview
Exhibit 117: Boehringer Ingelheim International GmbH - Business segments
Exhibit 118: Boehringer Ingelheim International GmbH - Key news
Exhibit 119: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 120: Boehringer Ingelheim International GmbH - Segment focus
12.6 Cipla Ltd.
Exhibit 121: Cipla Ltd. - Overview
Exhibit 122: Cipla Ltd. - Business segments
Exhibit 123: Cipla Ltd. - Key news
Exhibit 124: Cipla Ltd. - Key offerings
Exhibit 125: Cipla Ltd. - Segment focus
12.7 Endo International Plc
Exhibit 126: Endo International Plc - Overview
Exhibit 127: Endo International Plc - Business segments
Exhibit 128: Endo International Plc - Key news
Exhibit 129: Endo International Plc - Key offerings
Exhibit 130: Endo International Plc - Segment focus
12.8 GlaxoSmithKline Plc
Exhibit 131: GlaxoSmithKline Plc - Overview
Exhibit 132: GlaxoSmithKline Plc - Business segments
Exhibit 133: GlaxoSmithKline Plc - Key news
Exhibit 134: GlaxoSmithKline Plc - Key offerings
Exhibit 135: GlaxoSmithKline Plc - Segment focus
12.9 Medterra CBD
Exhibit 136: Medterra CBD - Overview
Exhibit 137: Medterra CBD - Product / Service
Exhibit 138: Medterra CBD - Key offerings
12.10 Novartis AG
Exhibit 139: Novartis AG - Overview
Exhibit 140: Novartis AG - Business segments
Exhibit 141: Novartis AG - Key offerings
Exhibit 142: Novartis AG - Segment focus
12.11 Perrigo Co. Plc
Exhibit 143: Perrigo Co. Plc - Overview
Exhibit 144: Perrigo Co. Plc - Business segments
Exhibit 145: Perrigo Co. Plc - Key news
Exhibit 146: Perrigo Co. Plc - Key offerings
Exhibit 147: Perrigo Co. Plc - Segment focus
12.12 Pfizer Inc.
Exhibit 148: Pfizer Inc. - Overview
Exhibit 149: Pfizer Inc. - Product / Service
Exhibit 150: Pfizer Inc. - Key news
Exhibit 151: Pfizer Inc. - Key offerings
12.13 Reckitt Benckiser Group Plc
Exhibit 152: Reckitt Benckiser Group Plc - Overview
Exhibit 153: Reckitt Benckiser Group Plc - Business segments
Exhibit 154: Reckitt Benckiser Group Plc - Key offerings
Exhibit 155: Reckitt Benckiser Group Plc - Segment focus
12.14 Sanofi
Exhibit 156: Sanofi - Overview
Exhibit 157: Sanofi - Business segments
Exhibit 158: Sanofi - Key news
Exhibit 159: Sanofi - Key offerings
Exhibit 160: Sanofi - Segment focus
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 164: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Viatris Inc.
Exhibit 168: Viatris Inc. - Overview
Exhibit 169: Viatris Inc. - Business segments
Exhibit 170: Viatris Inc. - Key news
Exhibit 171: Viatris Inc. - Key offerings
Exhibit 172: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations